NEC and Juniper Networks Deploy Algeria Telecom’s Nationwide 5G-Ready IP Metro Network
NEC Corporation (NEC; TSE: 6701), a leading global IT and network transformation services provider, and Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced they have worked with Algeria Telecom, the leader in the Algerian telecommunications market, to roll out its modernized, nationwide IP metro commercial network to support current demand for increased capacity as well as future needs driven by 5G and FTTx.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220524005904/en/
Algeria Telecom has formed a mid-term strategic plan to implement a transport network with a homogenized, optimized topology as well as automation capabilities that guarantee bandwidth and future-proofing of its infrastructure in a growing market. NEC and Juniper have successfully delivered Algeria Telecom’s next generation IP metro network while ensuring quality of service, driving toward the best possible user experience, at scale.
As the innovative foundation of the new platform, Algeria Telecom has selected high-performing, secure solutions from the Juniper Networks portfolio for SDN-ready, cloud-grade networking and feature-rich, simple and secure connectivity at scale, deployed as access nodes to create separate pre-aggregation, aggregation and access domains for optimal reliability. Elements of the Juniper Paragon Automation cloud-native solution suite, Paragon Pathfinder and Paragon Planner have been deployed, enabling Algeria Telecom to achieve deep visibility and simplified operations of its network and services. This paves the way for assured user experiences within complex 5G and multicloud services. All of the Juniper platforms run on a single operating system, Junos® OS, to create an easily-managed, simplified and open solution.
NEC leveraged its extensive transport network integration and engineering capabilities to skillfully deliver best-in-class solutions that are dynamically tailored for Algeria Telecom’s requirements. Moreover, NEC orchestrated the total project as a ‘One-Stop Network Integrator’, capitalizing on its professional services based on global and local experiences ranging from network analysis and consulting, to design, implementation, migration and operation of high-capacity networks.
In addition, NEC and Juniper’s solid partnership, built on a track record of delivering innovative networking to hundreds of customers across the globe, has enabled the tight coordination between the parties to achieve Algeria Telecom’s objective of providing a high-capacity innovative network to accommodate surging data traffic and a future of diversified 5G use cases.
"The successful completion of the IP metro network modernization project by our partners, NEC Corporation and Juniper Networks, will allow us to make the migration to IPV6 and the initiation of digital transformation, as well as the implementation of high speed internet, as we best satisfy the needs of Algeria Telecom customers," said Mr. Adel Bentoumi, CEO of Algeria Telecom.
“The rapid growth of network traffic is a clear indication of the need for modernization and expansion of network capacity,” said Allahoum Hocine, Head of IP Core, Algeria Telecom. “NEC and Juniper have been extremely attentive to our needs, both technical and commercial, working as an extension of our team with their outstanding local engineering abilities, as well as their relentless efforts to assure quality of experience and on-time delivery. Overall, the innovative solutions from Juniper to enable this automated metro cloud architecture have helped us achieve our strategic goals and thrive as we pave the way for 5G.”
“Networks have always been a key asset for service providers, but going forward they will be the foundation for every aspect of business transformation in the 5G and cloud era. Algeria Telecom is jumping ahead of the curve by investing in an open, agile and automated network architecture that can drive simplified operations, improved economics and superior end-user experiences,” said Brendan Gibbs, Senior Vice President, Automated WAN Solutions, Juniper Networks.
“Our customer-first approach and uncompromising quality are values that are deeply ingrained in our culture,” said Hideyuki Ogata, General Manager, Service Provider Solutions Department, NEC Corporation. “This, combined with our accumulated domain expertise at NEC 5G Transport Network Center of Excellence (CoE) in EMEA, makes us confident that our extended engagement through this partnership will help enable continuous success and advancement of Algeria Telecom’s business.”
Additional Resources:
The NEC-Juniper Global Alliance
About Algeria Telecom
Algeria Telecommunications Corporation (French: Algérie Télécom) is the state owned telecom operator in Algeria. It is a public company active in the fields of fixed phone and internet. Algérie Télécom was created on 5 August 2000.
For more information, visit Algeria Telecom at www.algerietelecom.dz
About Juniper Networks
Juniper Networks is dedicated to dramatically simplifying network operations and driving superior experiences for end users. Our solutions deliver industry-leading insight, automation, security and AI to drive real business results. We believe that powering connections will bring us closer together while empowering us all to solve the world’s greatest challenges of well-being, sustainability and equality. Additional information can be found at Juniper Networks (www.juniper.net) or connect with Juniper on Twitter, LinkedIn and Facebook.
Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.
About NEC Corporation
NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at http://www.nec.com.
LinkedIn: https://www.linkedin.com/company/nec/
YouTube: https://www.youtube.com/user/NECglobalOfficial
Facebook: https://www.facebook.com/nec.global/
Twitter: https://twitter.com/NEC_corp
NEC is a registered trademark of NEC Corporation. All Rights Reserved. Other product or service marks mentioned herein are the trademarks of their respective owners. ©2022 NEC Corporation.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220524005904/en/
Contact information
Penny Still
Juniper Networks
pstill@juniper.net
+44 (0) 1372 385 692
Joseph Jasper
NEC Corporation
j-jasper@nec.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 11:00:00 EET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 11:00:00 EET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 11:00:00 EET | Press release
Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 10:00:00 EET | Press release
Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of
Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 09:44:00 EET | Press release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom